Loading organizations...
Key people at Bio + Health.
Bio + Health was founded in 2011 by Richard Bendis (Founder, President, and CEO).
Biohealth operates as a contract manufacturer specializing in the production of nutritional supplements and health food solutions. Based in Germany, the company provides comprehensive services to partners seeking to develop and bring new health products to market. Their approach combines specialized manufacturing capabilities with a focus on quality standards to deliver diverse health-oriented items.
Biohealth International was founded in 2003 by Rudolf Gebhardt. Starting from modest beginnings with a small team and family members, Gebhardt steered the company's growth. Over two decades, it evolved into a significant enterprise, employing around 220 permanent staff at its Münchberg, Bavaria facility.
The company serves other brands and businesses in the health and wellness sector, acting as a crucial production partner for dietary supplements and health food lines. Biohealth envisions itself as a long-term strategic ally for its clients, enabling them to expand product portfolios. They aim to sustain growth by maintaining their German manufacturing base and commitment to quality.
Bio + Health was founded in 2011 by Richard Bendis (Founder, President, and CEO).
Key people at Bio + Health.
Bio + Health has 2 tracked investments across 2 companies. The latest tracked deal is $170.0M Series D in BioAge Labs in February 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2024 | BioAge Labs | $170.0M Series D | Sofinnova Investments | F Prime Capital, Highbury Group, Johnson & Johnson Innovation, Third Rock Ventures, Uprising, Vzvc, Amgen Ventures, Cormorant Asset Management, Lilly Ventures, Patrick Enright, OrbiMed, Osage University Partners, Pivotal BioVenture Partners, RA Capital Management, RTW Investments, Sands Capital, SV Health Investors |
| Dec 1, 2023 | Tome Biosciences | $210.0M Series A | — | Andreessen Horowitz, ARCH Venture Partners, Bessemer Venture Partners, Daniel Lynch, GV, Polaris Partners, Timothy A. Springer, Alexandria Venture Investments, Jorge Conde, Bruker, Fujifilm, Longwood Fund, Alan Crane |